From the authors

European Respiratory Journal

Volumn 44, Issue 4, 2014, Pages 1098-1099

  Schleich, Florence N ^a   Louis, Renaud ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ASTHMA; CELL INFILTRATION; CLINICAL PRACTICE; CYTOLYSIS; EOSINOPHIL; EOSINOPHIL COUNT; HUMAN; INFECTION CONTROL; LETTER; LOEFFLER PNEUMONIA; MACROPHAGE; MEDICAL SOCIETY; PATHOPHYSIOLOGY; PHENOTYPE; PRESCRIPTION; QUESTIONNAIRE; RESPIRATORY TRACT ALLERGY; SPUTUM ANALYSIS; SYMPTOMATOLOGY; COMPLICATION; EOSINOPHILIA; MALE; METABOLISM; SPUTUM;

ASTHMA; EOSINOPHILIA; HUMANS; MALE; SPUTUM;

EID: 84907509912     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00118014     Document Type: Letter

References (10)

1. Schleich FN, Chevremont A, Paulus V, et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J 2014; 44: 97-108.
2. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224.
3. Van Den Berge M, Meijer RJ, Kerstjens HA, et al. PC20 adenosine 59-monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med 2001; 163: 1546-1550.
4. Louis R, Sele J, Henket M, et al. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy 2002; 57: 907-912.
5. Kulkarni NS, Hollins F, Sutcliffe A, et al. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma. J Allergy Clin Immunol 2010; 126: 61-69.
6. Pavord ID, Brightling CE, Woltmann G, et al. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353: 2213-2214.
7. Green RH, Brightling CE, Woltmann G, et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57: 875-879.
8. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43: 343-373.
9. Gibson PG. Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD. Eur Respir J 2013; 42: 891-892.
10. Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012; 380: 651-659.